Log in to your Inderes Free account to see all free content on this page.
Prolight Diagnostics
0.136
SEK
-4.23 %
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Be the first to follow this company
-4.23%
+1.49%
-2.16%
-11.11%
-17.07%
-53.1%
-86.25%
-93.86%
-68.37%
Prolight Diagnostics develops test systems in POCT (Point of care testing). The tests are used outside of hospital laboratories to enable rapid assessments of the health of patients. The company's POCT platform is under development with the intention of measuring various biomarkers simultaneously. An important component of the work is to reduce the time for test results, particularly important for patients with heart problems. The company was founded in 1999 and is based in Lund.
Read moreMarket cap
95.48M SEK
Turnover
232.65K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
21.2.
2025
Annual report '24
14.5.
2025
Interim report Q1'25
28.8.
2025
Interim report Q2'25
ShowingAll content types
Prolight strengthens IP portfolio by additional patent application
EMERGERS VALUE PROLIGHT DIAGNOSTICS AT 730 MSEK (0,9- 1,0 SEK PER SHARE)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio